Tudor Investment Corp’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Tudor Investment Corp’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,000	Closed	-$464K	–	3035
2023 Q3	$464K	Buy	+25,000	New	+$283K	﹤0.01%	1713
2020 Q4	–	Sell	-9,986	Closed	-$414K	–	1706
2020 Q3	$414K	Buy	+9,986	New	+$459K	0.02%	889
2015 Q2	–	Sell	-3,350	Closed	-$945K	–	1721
2015 Q1	$945K	Buy	+3,350	New	+$725K	0.03%	404

Tudor Investment Corp's ICPT Position: Q4 2023 in Review

Tudor Investment Corp sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 25,000 shares — an estimated $464K sold.

Tudor Investment Corp first reported a position in ICPT in Q1 2015 and held it in 3 quarters. The position peaked at $945K in Q1 2015. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Tudor Investment Corp reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Tudor Investment Corp sold 25,000 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $464K.
Tudor Investment Corp first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
Tudor Investment Corp's Intercept Pharmaceuticals, Inc. position peaked at $945K in Q1 2015.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Tudor Investment Corp's 13F filing for Q4 2023, filed 14 Feb 2024.